Peroxisome proliferator-activated receptor γ (PPARγ), the chief regulator of adipogenesis, has been acutely investigated as a molecular target for natural products in the development of anti-obesity treatments. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.